 |
Tom Davis (ed). Witnesses: Scott Leischow, Chief, Tobacco Control Research Branch, Nat. Cancer Inst.; Lee Peeler, Deputy Dir., Bureau of Consumer Protection, FTC; Robert Wallace, chmn. of the Comm. to Assess the Science Base for Tobacco Harm Reduction, Inst. of Med./Nat. Acad. of Sciences; Kathleen Stratton, Inst. of Med.; Michael Szymanczyck, chmn. & CEO, Philip Morris USA, Inc.; Dorothy Hatsukami, prof., Dept. of Psychiatry & Behavioral Science, Johns Hopkins Univ. School of Med.; Lynn Kozlowski, prof. & head of Dept. of Behavioral Health, Penn. State Univ.; David Sweanor, sr. legal counsel, Non-Smokers’ Rights Assoc.; David Burns, prof., San Diego School of Medicine, Univ. of Calif.; & Richard Verheij, exec. v.p., U.S. Smokeless Tobacco Co.
|
|
|
